| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ralf Paus | Q37381598 |
| Andrzej Slominski | Q39814267 | ||
| P2093 | author name string | Czarnetzki BM | |
| P2860 | cites work | Defining criteria for autoimmune diseases (Witebsky's postulates revisited) | Q28255257 |
| The molecular basis of allorecognition | Q28268279 | ||
| Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. | Q30463850 | ||
| A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase | Q33937361 | ||
| Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy | Q35237202 | ||
| Disorders of the nails and hair associated with human immunodeficiency virus infection | Q35683062 | ||
| The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas | Q36362111 | ||
| The psoriatic epidermal lesion and anagen hair growth may share the same "switch-on" mechanism | Q36989622 | ||
| Neuropeptides and inflammation: the role of substance P. | Q38203143 | ||
| Alopecia areata: more on pathogenesis and therapy | Q38609482 | ||
| A biologist's reflections on dermatology | Q39885426 | ||
| Autoimmune disease | Q40766849 | ||
| How the immune system recognizes invaders. | Q40766883 | ||
| Melanocytes as "sensory" and regulatory cells in the epidermis | Q40792109 | ||
| Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth | Q40823314 | ||
| Regulated expression of the major histocompatibility complex class I genes | Q40834679 | ||
| On the potential role of proopiomelanocortin in skin physiology and pathology | Q40855674 | ||
| Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes | Q40880037 | ||
| The skin immune system: progress in cutaneous biology | Q40883468 | ||
| Peptides naturally presented by MHC class I molecules | Q40898177 | ||
| Immune Privilege in Hair Growth | Q41139710 | ||
| Summary of alopecia areata research workshop and future research directions | Q41152360 | ||
| Are L-tyrosine and L-dopa hormone-like bioregulators? | Q41233274 | ||
| Alopecia areata incognita: a hypothesis | Q41355478 | ||
| Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity | Q41437267 | ||
| Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology | Q41493154 | ||
| HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines | Q41660416 | ||
| Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata | Q42070483 | ||
| Distribution of major histocompatibility antigens in normal skin | Q42455179 | ||
| Keratinocytes: key immunocytes of the integument. | Q42754824 | ||
| Identification of pigment cell antigens defined by vitiligo antibodies | Q43411231 | ||
| HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration | Q43920988 | ||
| Expression of extracellular matrix in hair follicle mesenchyme in alopecia areata | Q44143037 | ||
| Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo | Q44679183 | ||
| Incidence of alopecia areata in lupus erythematosus | Q44706043 | ||
| Differential Expression and Activity of Melanogenesis-Related Proteins During Induced Hair Growth in Mice | Q52238016 | ||
| The DEBR rat: an animal model of human alopecia areata. | Q52481763 | ||
| Immunohistologic and Ultrastructural Comparison of the Dermal Papilla and Hair Follicle Bulb from “Active” and “Normal” Areas of Alopecia Areata | Q52874726 | ||
| Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. | Q54235681 | ||
| Aberrant Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Hair-Follicle Epithelial Cells and Endothelial Leukocyte Adhesion Molecule-1 (ELAM-1) by Vascular Cells Are Important Adhesion-Molecule Alterations in Alopecia Areata | Q67688582 | ||
| Cell degeneration in alopecia areata. An ultrastructural study | Q67938148 | ||
| Alopecia areata. Autoreactive T cells are variably enriched in scalp lesions relative to peripheral blood | Q68008417 | ||
| HLA associations with alopecia areata | Q68055072 | ||
| Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice | Q68059037 | ||
| Topical Delivery Enhancement with Multilamellar Liposomes into Pilosebaceous Units: I. In Vitro Evaluation Using Fluorescent Techniques with the Hamster Ear Model | Q68159685 | ||
| HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance | Q68290554 | ||
| Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy | Q68757908 | ||
| Expression of HLA-DR by anagen hair follicles in alopecia areata | Q68947966 | ||
| Neuropharmacology of peptides in skin | Q69137894 | ||
| Immunologic aspects of hair loss | Q70144198 | ||
| Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family | Q70560378 | ||
| Cytolytic antibodies to melanocytes in vitiligo | Q70723942 | ||
| Alopecia areata: light and electron microscopic pathology of the regrowing white hair | Q71269743 | ||
| Phorbol-12-Myristate-13-Acetate-Treated Human Keratinocytes Express B7-Like Molecules That Serve a Costimulatory Role in T-Cell Activation | Q72071497 | ||
| Glucocorticoid effect on hair growth initiation: a reconsideration | Q72883757 | ||
| P433 | issue | 6 | |
| P921 | main subject | modelling biological systems | Q4299308 |
| alopecia areata | Q5075435 | ||
| autoimmune disease | Q8084905 | ||
| P304 | page(s) | 541-554 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? | |
| P478 | volume | 66 |
| Q33617937 | Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata |
| Q35569800 | Alopecia Areata Susceptibility in Rodent Models |
| Q35569792 | Alopecia Areata: Autoimmunity—The Evidence Is Compelling |
| Q38656135 | Alopecia Areata: a Comprehensive Review of Pathogenesis and Management |
| Q90115048 | Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept |
| Q60843765 | Alopecia areata |
| Q37720518 | Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies |
| Q48962612 | Association analysis of the HLA-C gene in Japanese alopecia areata. |
| Q36335826 | Association between PTPN22 C1858T polymorphism and alopecia areata risk |
| Q37376897 | Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice |
| Q39604573 | CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata |
| Q44791777 | Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. |
| Q38584881 | Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model |
| Q85190876 | Collapse of Immune Privilege in Alopecia Areata: Coincidental or Substantial? |
| Q36861222 | Efficacy of korean red ginseng in the treatment of alopecia areata |
| Q90589637 | Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients |
| Q37799893 | Hair follicle is a target of stress hormone and autoimmune reactions |
| Q45766327 | Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege. |
| Q55265385 | Human αβ and γδ T Cells in Skin Immunity and Disease. |
| Q58602752 | Immune Privilege Collapse and Alopecia Development: Is Stress a Factor |
| Q48164354 | Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors. |
| Q35916135 | Lymphocytes, neuropeptides, and genes involved in alopecia areata |
| Q91729705 | Pathomechanisms of immune-mediated alopecia |
| Q91991233 | Perinevoid Alopecia: A Case Report |
| Q36202856 | Probing the effects of stress mediators on the human hair follicle: substance P holds central position |
| Q27011716 | Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata |
| Q34205952 | Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model |
| Q93049089 | T-cell positioning by chemokines in autoimmune skin diseases |
| Q37272084 | The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. |
| Q47961485 | Transfer of alopecia areata in the human scalp graft/Prkdcscid (SCID) mouse system is characterized by a TH1 response |
| Q33889367 | What causes alopecia areata? |
Search more.